Navigation Links
TrialScope Welcomes Moderna Into Its Community of Clinical Trial Sponsors

TrialScope, the global leader in clinical trial disclosure and transparency management technology, is proud to announce the addition of Moderna to its growing customer roster.

TrialScope customers include 16 of the top 20 industry sponsors, who rely on its technology for trial disclosure management, patient engagement and study recruitment. Collectively, TrialScope customers are responsible for more than 40 percent of all industry trials on and the EU-CTR.

Moderna has selected the TrialScope Disclose™ platform to manage and automate its clinical trial disclosure process, maintain regulatory compliance and enhance its transparency efforts. In addition, with its trial information securely housed in the TrialScope Transparency Cloud™, Moderna will benefit from a single source that promotes consistency of data and facilitates repurposing data for increased efficiencies.

To complement use of the TrialScope Disclose platform, Moderna will avail itself of clinical trial disclosure services offered by TrialScope. These services – including protocol registration, results disclosure, plain-language summaries and redaction of potentially confidential information – are designed to help ease the workload of disclosure teams at organizations of all sizes.

This partnership comes at a crucial time for Moderna, which is a top contender for a COVID-19 vaccine. The federal government is supporting Moderna’s vaccine project with nearly $500 million and has chosen it as one of the first to enter large-scale human trials.

“Moderna is committed to clinical trial disclosure and transparency,” said Lakshmi Ramkumar, Head of Medical Writing. “Partnering with industry-leader TrialScope enables us track, fulfill and report on global commitments via one end-to-end platform.”

“We are excited to share our technology and our expertise with Moderna,” said TrialScope CEO Jeff Kozloff. “While the coronavirus pandemic has proved a monumental challenge for people across the globe, Moderna is at the forefront of the fight, and we are thrilled to play a small but important supporting role.”

For more information on TrialScope or TrialScope Disclose, visit

About TrialScope

TrialScope gives your clinical trial data superpowers™. The TrialScope Transparency Cloud™ makes centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 16 of the top 20 clinical trial sponsors in the world, who rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit

About Moderna

Headquartered in Cambridge, Mass., Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators. The company has been ranked in the top ten of Science’s list of top biopharma industry employers for the past five years. To learn more, visit

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related medicine technology :

1. The Riviera Maya Welcomes Its First Visitors with the "New Normal"
2. Associated Oral and Implant Surgeons Welcomes Oral Surgeon Dr. Ryan Dowling to their Practice Serving Kingsport, Johnson City, and Bristol, TN
3. Kyle Parkway Dentistry Welcomes Dr. Emily Zaramella to the Practice.
4. Leading Miami Healthcare Advertising Agency Welcomes National and Local Clients
5. iPatientCare National User Conference 2019 welcomes Amazon Web Services as Grand Sponsor and exhibitor
6. FSSolutions Welcomes Mark Lutz, MA, LCDC, IDAC, to Lead the Sales Strategy for their Revolutionary New Recovery Management Platform, CaseFLO
7. The Smiles for Everyone Foundation Welcomes Applicants for Implant Program
8. AAEM Physician Group Welcomes South Bend Emergency Physicians of Indiana
9. Excelera® Specialty Pharmacy Network Welcomes HonorHealth
10. PAINWeek 2019 Welcomes the International Myopain Society
11. Gwinnett Family Dental Care Welcomes New Dentist Dr. Dhruva Patel
Post Your Comments:
(Date:8/11/2020)... ... August 11, 2020 , ... Emler Swim School , an award-winning ... teaching millions of swim lessons, is excited to offer two complimentary lessons as part ... try the program before they buy it. , Last month Emler unveiled EmlerSWIM@Home™ ...
(Date:8/11/2020)... , ... August 11, 2020 , ... RCare, Inc. (Response ... over the past 6 months. This has been largely due to new major product ... need during the pandemic. RCare designed and custom-built the Rapid Deployment Kit (RDK), a ...
(Date:8/8/2020)... ... ... all know that there are two good ways to fight COVID-19. One is to wash ... The other is to disinfect high touch surfaces, according to the CDC. , When we ... come to mind. , But what about your car? , While you might not think ...
Breaking Medicine Technology:
(Date:8/5/2020)... ... August 05, 2020 , ... In its often-heroic ongoing ... challenges. Regardless of the obstacle - shortages of tests, ventilators and ICU beds; ... cancellation or postponement of all nonessential services - providers across the country have ...
(Date:8/5/2020)... ... August 05, 2020 , ... The Veterinary Cooperative named ... the largest veterinarian-owned purchasing Cooperative in the United States. , Hamele has spent ... gained extensive knowledge and experience in the animal health industry. In her most ...
(Date:8/5/2020)... Wis. (PRWEB) , ... August 04, 2020 , ... ... the care of children with Autism Spectrum Disorder (ASD) in Wisconsin, is delighted ... Brookfield, Wisconsin . With the opening of their newest center, Total Spectrum now ...
(Date:8/3/2020)... ... 2020 , ... Evolution Labs announced today that St. Lucie ... developed to help students navigate a range of issues related to Mental Health, ... provide their students with preventative lessons after recent studies of social media impact ...
(Date:8/3/2020)... ... August 03, 2020 , ... Actuate Therapeutics, Inc. (Actuate), ... first-line advanced pancreatic cancer in a phase 2 study of 9-ING-41, as a ... 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 beta (GSK-3ß) inhibitor ...
Breaking Medicine News(10 mins):